AriVac is proud to announce a major $4 million investment to upgrade our facilities and technology. This milestone reflects our commitment to meeting the highest standards in veterinary and agri-food diagnostics. The funding will support essential upgrades at our Saint-Hyacinthe site and enable the launch of innovative products, such as a specialized disinfectant and advanced animal health diagnostic kits.
Since 2003, AriVac has grown from a single team member to a dynamic workforce of fifteen, with three new roles to be added soon. This investment empowers us to diversify further, including vaccine production for animal health, with valuable support from the local development center (CLD).